Frank H. Valone
2015
In 2015, Frank H. Valone earned a total compensation of $2.9M as Senior Fellow, Clinical Development formerly Chief Medical Officer at FibroGen, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $227,240 |
|---|---|
| Option Awards | $1,205,193 |
| Salary | $460,000 |
| Stock Awards | $1,019,058 |
| Other | $16,831 |
| Total | $2,928,322 |
Valone received $1.2M in option awards, accounting for 41% of the total pay in 2015.
Valone also received $227.2K in non-equity incentive plan, $460K in salary, $1M in stock awards and $16.8K in other compensation.
Rankings
In 2015, Frank H. Valone's compensation ranked 3,252nd out of 13,638 executives tracked by ExecPay. In other words, Valone earned more than 76.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,252 out of 13,638 | 76th |
Division Manufacturing | 1,177 out of 5,187 | 77th |
Major group Chemicals And Allied Products | 425 out of 1,857 | 77th |
Industry group Drugs | 336 out of 1,531 | 78th |
Industry Pharmaceutical Preparations | 268 out of 1,179 | 77th |
Source: SEC filing on April 24, 2017.
Valone's colleagues
We found three more compensation records of executives who worked with Frank H. Valone at FibroGen in 2015.